Answers are grounded in this paper and cite their sources.
Demonstrates the efficacy of PGE1 injections in diagnosing erectile dysfunction, suggesting beneficial insights for treatment plans.
Introduction Even now, vascular evaluations of the penile cavernous artery using PGE1 injections have not become widespread in Japan. Unfortunately, they are only performed at a limited number of facilities. Objective We studied self-experiment cases to verify the current state of Prostaglandin E1 (PGE1) test. Methods We focused on 76 patients of the PGE1 test. All patients received a PGE1 (20μg) injection followed by the results based on response scores. When available, color Doppler ultrasonography was conducted to measure peak systolic velocity. Results Among all patients aged between 16 and 81 years old, 16 patients were in their 60s, the highest number of all age groups, 14 in their 30s, 12 in their 20s, 10 each in their 40s and 50s, 4 in their 70s, 3 teens, and 2 in their 80s. Responses to PGE1 were Response 1 in 19cases, Response 2 in 13cases, Response 3 in 43cases and Response 4 in 1 case Response 1 cases were more likely to be cases in which PDE5 inhibitors were ineffective and further evaluation was performed. On the other hand, Response 3 cases were more likely to be psychogenic ED or neurogenic ED. Color Doppler ultrasonography was performed in five cases in Response 1, and peak systolic velocity was reduced in all cases. In the 26 cases in Response 3, 16 were normal. Conclusions The vascular examination of the penile cavernous artery using a PGE1 injection was useful for determining subsequent treatment. Disclosure No
No takes yet. Share an insight, caveat, or question.
Kikuchi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: